| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |